Hot Oil Service Stocks To Buy Right Now

Next Monday, Halliburton (NYSE: HAL  ) will release its latest quarterly results. The key to making smart investment decisions on stocks reporting earnings is to anticipate how they'll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise. That way, you'll be less likely to make an uninformed knee-jerk reaction to news that turns out to be exactly the wrong move.

Halliburton has thrived in the U.S. energy boom, but weak energy prices have raised questions about whether production activity will decline and cause a drop in demand for oil services. Let's take an early look at what's been happening with Halliburton over the past quarter and what we're likely to see in its quarterly report.

Stats on Halliburton

Analyst EPS Estimate

$0.57

Change From Year-Ago EPS

Best Defensive Companies To Own In Right Now: Zogenix Inc (ZGNX)

Zogenix, Inc. (Zogenix), incorporated on May 11, 2006, is a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain. The Company�� product Sumavel DosePro offers needle-free subcutaneous administration of sumatriptan for the treatment of migraine and cluster headache in a pre-filled, single-use delivery system. Its lead product candidate, Zohydro (hydrocodone bitartrate, formerly ZX002) is a 12-hour extended-release formulation of hydrocodone without acetaminophen for the treatment of chronic pain requiring opioid therapy. It completed Phase 3 development of Zohydro in 2011. Its second DosePro investigational product candidate, Relday, is a injectable formulation of risperidone for the treatment of schizophrenia. Sumavel DosePro and Zohydro are used for the treatment options available to patients and physicians in the United States. Sumavel DosePro may serve as a treatment alternative to oral and nasal triptans and offers administration when compared to traditional, needle-based sumatriptan injection. In May, 2012, it submitted a New Drug Application to the Food and Drug Administration (FDA).

The Company�� collaboration with Astellas has been terminated on March 31, 2012. Sumavel DosePro is a pre-filled, single-use disposable, needle-free drug delivery system that subcutaneously delivers 6 mg of sumatriptan in 0.5 mL of sterile liquid. Sumavel DosePro is designed to be portable, intuitive and easy-to-use. To use, the patient simply snaps off a plastic tip, flips back a lever and presses the end of the delivery system to the skin of the abdomen or thigh. Under the force of a small amount of compressed nitrogen gas, the liquid form of sumatriptan is expelled out of the device as a thin jet of medication, which pierces the skin and selectively deposits into the subcutaneous tissue.

Zogenix competes with GlaxoSmithKline, AstraZeneca PLC, Endo Pharmaceuticals Holdings Inc., Johnson & Johnson, Merck & Co., ! Inc., Pfizer Inc., Alexza Pharmaceuticals, Inc., MAP Pharmaceuticals, Inc., Abbott Laboratories, Alpharma Inc., Endo Pharmaceuticals Holdings Inc., King Pharmaceuticals, Inc., Mallinckrodt Inc., Purdue Pharma L.P., Teva Pharmaceutical Industries Limited, Watson Pharmaceuticals, Inc., Becton, Dickinson and Company, Owen Mumford Ltd., Ypsomed, Sandoz Inc., Bioject Inc. and Antares Pharma Inc.

Advisors' Opinion:

• [By Lauren Pollock]

  The Food and Drug Administration approved an extended-release version of the narcotic painkiller hydrocodone despite a recommendation by its advisory committee that the drug should be rejected because of its potential for abuse. The federal agency approved Zohydro ER from Zogenix Inc.(ZGNX), the first hydrocodone product not mixed with milder painkillers such as acetaminophen and also the first extended-release hydrocodone product. Shares rose 15% to $3.49 premarket.

Hot Oil Service Stocks To Buy Right Now: Emerson Electric Company(EMR)

Emerson Electric Co. operates as a diversified manufacturing and technology company. The company engages in appliance solutions, climate technologies, industrial automation, motor technology, network power, process management, professional tools, and storage solutions businesses. Its appliance solutions business provides appliance controls, appliance motors, heating products, and white-rodgers; climate technology business provides heating, ventilation, air conditioning, and refrigeration (HVACR) solutions for residential, industrial, and commercial applications; and industrial automation business offers bearings and power transmission products, electrical power generation products, electric motors, variable speed drives and servos, electrical products, material joining solutions, fluid automation products, and wind turbine systems. The company?s motor technology business provides appliance motors, HVACR motors, DC motors, fractional horsepower motors, integral horsepower a nd larger motors, and drives; network power business provides power, precision cooling, connectivity, and embedded solutions; and process management business provides various wireless related products from self-organizing field networks to wireless asset and people tracking. Its professional tools business offers pipe working and threading equipment, pressing technology, utility locating and visual diagnostics systems, drain maintenance tools, power tools, air tools, general purpose hand tools, wet/dry vacs, job site storage equipment, truck tool boxes and equipment, and van storage equipment; and storage solutions business provides shelving and storage products for residential, commercial, and foodservice needs, as well as offers specialized carts, mobile computer workstations, and cabinet fixtures. The company was founded in 1890 and is headquartered in St. Louis, Missouri.

Advisors' Opinion:

• [By Ben Levisohn]

  Barclays’ Scott Davis and team believe it might be, and for evidence they look at�3M (MMM), Emerson Electric (EMR), Rockwell Automation (ROK), and MSC Industrial Direct (MSM). They write:

Hot Oil Service Stocks To Buy Right Now: GFI Group Inc. (GFIG)

GFI Group Inc. provides wholesale brokerage, clearing, electronic execution, and trading support products for financial markets. The company offers brokerage and trade execution services, clearing services, market data and trading platform, and other software products to institutional customers. The company provides brokerage services in fixed income derivatives, bond instruments, and other related products; financial instruments, including foreign exchange options, exotic options, non-U.S. Dollar interest rate swaps and options, repurchase agreements, forward and non-deliverable forward contracts, and government and municipal bond options; cash-based and derivative equity products, such as the U.S. domestic and international equity stocks, global depositary receipts, American depositary receipts, and equity derivatives; and cash-based and derivative commodity, and energy products comprising oil, natural gas, biofuel, electricity, wet and dry freight derivatives, dry physi cal freight, precious metals, coal, property derivatives, emissions, ethanol, and soft commodities. It also offers clearing, brokerage, settlement, and back-office services to proprietary traders, brokers, market makers, and hedge funds; provides capital to start-up trading groups, small hedge funds, market-makers, and individual traders; licenses multi-asset class electronic trading and order management software to brokers, exchanges, and traders in the commodities, fixed income, currencies, and equities markets; and offers FENICS Professional, a suite of price discovery, price distribution, trading, risk management, and straight-through processing components. The company primarily serves investment and commercial banks, large corporations, asset managers, insurance companies, hedge funds, and proprietary trading firms in the Americas; Europe, the Middle East, and Africa; and Asia. GFI Group Inc. was founded in 1987 and is headquartered in New York, New York.

Advisors' Opinion:

• [By Jayson Derrick]

  CME Group (NYSE: CME) has agreed to acquire GFI Group (NASDAQ: GFIG) for $4.55 per share and will immediately sell it's wholesale brokerage and clearing business back to a group led by GFI Management. CME will retain GFI Group's Trayport which provides trading software in the European energy markets as well as FENICS, a provider of price discovery, analytics, risk-management and workflow connectivity services for over the counter foreign exchange options markets. Shares of CME Group gained 0.44 percent, closing at $75.83 while shares of GFI Group surged to new 52-week highs of $4.50 before closing the day at $4.47, up 43.73 percent.

Hot Oil Service Stocks To Buy Right Now: Covidien PLC (COV)

Covidien Public Limited Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. It operates its businesses through three segments: Medical Devices, which includes the development, manufacture and sale of endomechanical instruments, energy devices, soft tissue repair products, vascular products, oximetry and monitoring products, airway and ventilation products; Pharmaceuticals, which includes the development, manufacture and distribution of specialty pharmaceuticals and active pharmaceutical ingredients, and Medical Supplies, SharpSafety products and original equipment manufacturer products. In May 2012, it acquired Newport Medical Instruments, Inc. In May 2012, it acquired superDimension, Ltd. In June 2012, the Company acquired Oridion Systems Ltd. In October 2012, its Mallinckrodt acquired CNS Therapeutics, Inc. In January 2013, the Company acquired CV Ingenuity. Advisors' Opinion:

• [By Garrett Cook]

  Medtronic (NYSE: MDT) announced its plans to buy Covidien plc (NYSE: COV) for $42.9 billion in cash and stock.

  Medtronic will offer $93.22 per share for Covidien, representing a 29% premium over Covidien's closing price on Friday.

Hot Oil Service Stocks To Buy Right Now: Apollo Commercial Real Estate Finance (ARI)

Apollo Commercial Real Estate Finance, Inc., a real estate investment trust, engages in originating, acquiring, investing in, and managing performing commercial first mortgage loans, commercial mortgage-backed securities, mezzanine financings, and other commercial real estate-related debt investments in the United States. The company is qualified as a real estate investment trust (REIT) under the Internal Revenue Code. As a REIT, it would not be subject to federal income taxes, if it distributes at least 90% of its REIT taxable income to its stockholders. The company was founded in 2009 and is headquartered in New York, New York.

Advisors' Opinion:

• [By Rich Duprey]

  Mortgage real estate investment trust�Apollo Commercial Real Estate Finance� (NYSE: ARI  ) announced this morning its second-quarter dividend for its 8.625% Series A cumulative redeemable perpetual preferred stock�of $0.5391�per share for the period ending July 15. That's the same rate it's paid for the past three quarters after it was increased 21% from $0.4432 per share.

Hot Oil Service Stocks To Buy Right Now: GlaxoSmithKline PLC(GSK)

GlaxoSmithKline plc, together with its subsidiaries, engages in the discovery, development, manufacture, and marketing of pharmaceutical products, over the counter (OTC) medicines, and health-related consumer products worldwide. It offers pharmaceutical products in various therapeutic areas comprising respiratory, HIV, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, oncology and emesis, vaccines, and dermatologicals. The company provides prescription medicines to treat a range of conditions, including infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer. It also markets a range of vaccines to prevent life-threatening or crippling illnesses, such as hepatitis A, hepatitis B, diphtheria, tetanus, whooping cough, measles, mumps, rubella, polio, typhoid, influenza, and bacterial meningitis. In addition, the company provides OTC medicines, including Panadol, a paracetamol-based treatment of headache and joi nt pain, fever, and cold symptoms; Gaviscon, a range of antacid products that relieve heartburn due to acid reflux; and NicoDerm, NiQuitin CQ, Nicabate, and Nicorette for the treatment of nicotine withdrawal as an aid to quit smoking. Further, it offers oral healthcare products comprising Sensodyne, a range of toothpastes and toothbrushes for the prevention of dental sensitivity; Aquafresh, a range of toothpastes, toothbrushes, and mouthwashes; and Polident, Poligrip, and Corega, which are denture adhesives and cleansers. Additionally, the company provides nutritional healthcare products consisting of Lucozade, an energy and sports drinks for energy and hydration; Horlicks, a malted, milk-based drink and food for nutrition application; and Ribena, an apple, orange, raspberry, and pomegranate flavored fruit drink, as well as markets skincare products. GlaxoSmithKline plc was incorporated in 1999 and is headquartered in Brentford, United Kingdom.

Advisors' Opinion:

• [By Lee Jackson]

  Johnson & Johnson (NYSE: JNJ) recently became a player in the very aggressive and lucrative hepatitis C market when it purchased GlaxoSmithKline PLC’s (NYSE: GSK) treatment. This combined with its huge portfolio of products makes the stock a top diversified portfolio holding. The consensus price objective for the stock is $95. Investors are paid a 3.0% dividend. Johnson & Johnson closed Thursday at $87.78.

• [By Zarr Pacificador]

  A look at GlaxoSmithKline
  Today I'm evaluating�GlaxoSmithKline� (LSE: GSK  ) (NYSE: GSK  ) , a British global pharmaceutical company,�which currently trades at 1550 pence. Here are my thoughts: